Richard Klausner's Net Worth
$84.4 Million
Who is Richard Klausner?
Richard Klausner has an estimated net worth of $84.4 Million. This is based on reported shares across multiple companies, which include ILLUMINA INC, Lyell Immunopharma, Inc., and Juno Therapeutics, Inc..
SEC CIK
Richard Klausner's CIK is 0001591178
Past Insider Trading and Trends
2017 was Richard Klausner's most active year for acquiring shares with 5 total transactions. Richard Klausner's most active month to acquire stocks was the month of May. 2015 was Richard Klausner's most active year for disposing of shares, totalling 17 transactions. Richard Klausner's most active month to dispose stocks was the month of February. 2021 saw Richard Klausner paying a total of $0.00 for 3,765,842 shares, this is the most they've acquired in one year. In 2018 Richard Klausner cashed out on 777,499 shares for a total of $63,617,786.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ILLUMINA INC (ILMN) Snapshot price: $142.6
Sr VP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.10% | -253.00 |
$157.95 | -$39,961.35 | 22.85K |
Jan 29
| |||
Form 4
| -3.06% | -730.00 |
$163.52 | -$119,369.60 | 23.1K |
Scheduled
|
Nov 13
| ||
Form 4
| -0.77% | -186.00 |
$154.75 | -$28,783.50 | 23.83K |
Nov 5
| |||
Form 4
| -1.73% | -423.00 |
$173.20 | -$73,263.60 | 24.02K |
Scheduled
|
Sep 28
| ||
Form 4
| -2.04% | -509.00 |
$189.93 | -$96,674.37 | 24.44K |
Sep 23
| |||
Form 4
| -4.54% | -1.19K |
$191.75 | -$227,415.50 | 24.95K |
Scheduled
|
Mar 10
| ||
Form 4
| -0.93% | -246.00 |
$200.00 | -$49,200.00 | 26.13K |
Jan 29
| |||
Form 4
| +8.09% | 1.98K |
—
|
—
| 26.38K |
Dec 5
| |||
Form 4
| -2.04% | -509.00 |
$167.27 | -$85,140.43 | 24.41K |
Sep 23
| |||
Form 4
| +10.39% | 2.34K |
—
|
—
| 24.91K |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.77
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
| -5.87% | -58.02K |
$2.28 | -$132,285.60 | 930.88K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -1.11% | -11.10K |
$6.40 | -$71,041.11 | 988.9K |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
∞
| 3.77M |
—
|
—
| 3.77M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Juno Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -728.77K |
$87.00 | -$61,380,675.00 |
0
|
Feb 7 - Mar 5
| |||
Form 4
| -1.68% | -12.48K |
$48.21 | -$613,391.64 | 728.77K |
Scheduled
|
Jan 5 - Jan 8
| ||
Form 4
| -4.63% | -36.00K |
$44.76 | -$1,611,356.18 | 741.25K |
Scheduled
|
Dec 21
| ||
Form 4
| +0.03% | 266 |
—
|
—
| 777.25K |
Oct 5
| |||
Form 4
| -1.52% | -12.00K |
$42.66 | -$511,865.47 | 776.99K |
Scheduled
|
Sep 7
| ||
Form 4
| -1.50% | -12.00K |
$30.34 | -$364,090.80 | 788.99K |
Scheduled
|
Aug 7
| ||
Form 4
| -2.86% | -23.62K |
$29.39 | -$705,319.80 | 800.99K |
Scheduled
|
Jul 5 - Jul 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -2.83% | -24.00K |
$23.60 | -$566,361.70 | 824.61K |
Scheduled
|
Jun 7
| ||
Form 4
| +0.06% | 514 |
—
|
—
| 848.61K |
Apr 5
| |||
Form 4
| +0.07% | 591 |
—
|
—
| 848.09K |
Jan 5
| |||
Form 4
| +0.05% | 401 |
—
|
—
| 847.5K |
Oct 5
| |||
Form 4
| +0.04% | 300 |
—
|
—
| 847.1K |
Jul 5
| |||
Form 4
| -1.40% | -12.00K |
$40.71 | -$488,496.00 | 846.8K |
Scheduled
|
Jun 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| -1.38% | -12.00K |
$40.00 | -$480,000.00 | 858.8K |
Scheduled
|
May 18
| ||
Form 4
| -1.36% | -12.00K |
$42.90 | -$514,857.16 | 870.8K |
Scheduled
|
Apr 15
| ||
Form 4
| +0.03% | 300 |
—
|
—
| 882.8K |
Apr 5
| |||
Form 4
| -1.34% | -12.00K |
$40.00 | -$480,000.00 | 882.5K |
Scheduled
|
Mar 22
| ||
Form 4
| -2.61% | -24.00K |
$40.42 | -$970,023.03 | 894.5K |
Scheduled
|
Mar 2
| ||
Form 4
| -1.29% | -12.00K |
$45.71 | -$548,561.74 | 918.5K |
Scheduled
|
Dec 15
| ||
Form 4
| -1.27% | -12.00K |
$49.51 | -$594,077.65 | 930.5K |
Scheduled
|
Nov 13
| ||
Form 4
| -0.84% | -8.00K |
$50.00 | -$400,000.00 | 942.5K |
Scheduled
|
Oct 15
| ||
Form 4
| -1.66% | -16.00K |
$50.00 | -$800,008.00 | 950.5K |
Scheduled
|
Oct 12
| ||
Form 4
| -0.82% | -8.00K |
$53.34 | -$426,726.66 | 966.5K |
Scheduled
|
Jul 15
| ||
Form 4
| -0.81% | -8.00K |
$52.29 | -$418,302.09 | 974.5K |
Scheduled
|
Jun 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||